IP Library Granted Patent US 9,238,616
Granted Patent B2
US 9,238,616 · App. 14/792,243 · Granted Jan 19, 2016

Prodrugs of gaba analogs, compositions and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,238,616
App. No.
14/792,243
Granted
Jan 19, 2016
Kind
B2
Abstract

The present invention provides prodrugs of GABA analogs, pharmaceutical compositions of prodrugs of GABA analogs and methods for making prodrugs of GABA analogs. The present invention also provides methods for using prodrugs of GABA analogs and methods for using pharmaceutical compositions of prodrugs of GABA analogs for treating or preventing common diseases and/or disorders.

Claims (15)

1. A compound of Formula (I):

or a pharmaceutically acceptable salt thereof, wherein

X is oxygen;

n is 0;

each of R1, R3, R6 and R7 is hydrogen;

Y is oxygen; and

R4 and R5, together with the carbon atom to which they are attached, form a C 7 -cycloalkenyl ring that is substituted with an ethanyl moiety.

2. The compound of claim 1 , comprising a pharmaceutically acceptable salt.

3. The compound of claim 2 , wherein the salt is a benzene sulfonic acid salt.

4. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 .

5. A method for treating epilepsy, depression, anxiety, psychosis, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, panic, pain, inflammatory disease, insomnia, gastrointestinal disorders or ethanol withdrawal syndrome in a patient, comprising administering to a patient in need of such treatment a therapeutically effective amount of a compound of claim 1 .

6. The method of claim 5 , comprising treating pain.

7. The method of claim 6 , comprising treating neuropathic pain.

8. The method of claim 5 , for treating anxiety.

9. The method of claim 5 , for treating epilepsy.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2021
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ARBOR PHARMACEUTICALS, LLC; WILSHIRE PHARMACEUTICALS, INC.; XENOPORT, INC.
Reel/Frame 057880/0174 →
SECURITY INTEREST Recorded Sep 20, 2021
From: ARBOR PHARMACEUTICALS, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057544/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 25, 2018
From: XENOPORT, INC.
To: ARBOR PHARMACEUTICALS, LLC
Reel/Frame 046633/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2018
From: ARBOR PHARMACEUTICALS, LLC
To: XENOPORT, INC.
Reel/Frame 046449/0306 →
SECURITY INTEREST Recorded Jul 6, 2016
From: ARBOR PHARMACEUTICALS, LLC; XENOPORT, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 039266/0345 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 7, 2015
From: GALLOP, MARK A.
To: XENOPORT, INC.
Reel/Frame 036005/0152 →